Study examines development of early COPD in ages 30 to 55
Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing ...
Gloucester Daily Times1d
SENIOR LOOKOUT: What you should know about COPD
November is COPD Awareness Month. Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of death in the U.S. behind ...
ktiv3d
Healthbeat 4: What is chronic obstructive pulmonary disease and how do you prevent it?
SIOUX CITY (KTIV) - The World Health Organization says chronic obstructive pulmonary disease (COPD) is the third leading ...
India Today on MSN12h
Air pollution is the leading cause of COPD: Why is this lung disease deadly
Delhi's air pollution has reached severe levels, raising health concerns for those with chronic respiratory diseases like ...
McKnight's Long-Term Care News1d
COPD patients who are socially isolated face higher risk of death, data shows
The risk for all-cause death was higher in older adults with chronic obstructive pulmonary disease (COPD) who experienced social isolation compared to those who were more socially connected to others, ...
India Today on MSN11h
What is COPD, the deadly lung disease?
Chronic Obstructive Pulmonary Disease (COPD) is a major health issue globally, primarily caused by smoking and environmental ...
Medical Xpress8d
Increased focus on comorbidities, socioeconomic factors could help improve health equity for people with COPD
Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease, comprising several conditions, including ...
Yahoo Finance2d
Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
After years of limited advancements in chronic obstructive pulmonary disease (COPD) treatment, patients now have new options.
The killer disease ‘silently suffocating NHS’ and causing thousands of deaths a year – are you at risk?
A DISEASE that contributed to hundreds of thousands of emergency hospital admissions last winter needs the same urgency and ...
Managed Healthcare Executive1d
FDA Sets Date For Resubmitted Dupixent in Inflammatory Skin Disease
The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...
Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.